Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments, Epigenetics and DNA Methylation, and Pancreatic and Hepatic Oncology Research.
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures
Pan-cancer proteogenomics characterization of tumor immunity
Multi-scale signaling and tumor evolution in high-grade gliomas
Comprehensive proteogenomic characterization of rare kidney tumors
Proteogenomic data and resources for pan-cancer analysis
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
Pan-cancer proteogenomics connects oncogenic drivers to functional states
Proteogenomic insights suggest druggable pathways in endometrial carcinoma
Deep learning integrates histopathology and proteogenomics at a pan-cancer level
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Proteogenomic characterization of pancreatic ductal adenocarcinoma
A proteogenomic portrait of lung squamous cell carcinoma
Aberrant CREB1 activation in prostate cancer disrupts normal prostate luminal cell differentiation
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Notch3 promotes prostate cancer-induced bone lesion development via MMP-3
Glycan Motif Profiling Reveals Plasma Sialyl-Lewis X Elevations in Pancreatic Cancers That Are Negative for Sialyl-Lewis A *
Transient Induction of ING4 by Myc Drives Prostate Epithelial Cell Differentiation and Its Disruption Drives Prostate Tumorigenesis
Hypoxia Triggers Hedgehog-Mediated Tumor–Stromal Interactions in Pancreatic Cancer
Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells
Negative Regulation of NF-κB by the ING4 Tumor Suppressor in Breast Cancer